Atlas Trials

A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers

Clinical trial NCT02045524 · COMPLETED

Trial details

NCT number
NCT02045524
Sponsor
JDP Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Urticaria
Start date
2011-08-01
Primary completion
2011-09-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.